Literature DB >> 30597486

Limitations and Misinterpretations of E-Values for Sensitivity Analyses of Observational Studies.

John P A Ioannidis1, Yuan Jin Tan2, Manuel R Blum3.   

Abstract

The E-value was recently introduced on the basis of earlier work as "the minimum strength of association…that an unmeasured confounder would need to have with both the treatment and the outcome to fully explain away a specific treatment-outcome association, conditional on the measured covariates." E-values have been proposed for wide application in observational studies evaluating causality. However, they have limitations and are prone to misinterpretation. E-values have a monotonic, almost linear relationship with effect estimates and thus offer no additional information beyond what effect estimates can convey. Whereas effect estimates are based on real data, E-values may make unrealistic assumptions. No general rule can exist about what is a "small enough" E-value, and users of the biomedical literature are not familiar with how to interpret a range of E-values. Problems arise for any measure dependent on effect estimates and their CIs-for example, bias due to selective reporting and dependence on choice of exposure contrast and level of confidence. The automation of E-values may give an excuse not to think seriously about confounding. Moreover, biases other than confounding may still undermine results. Instead of misused or misinterpreted E-values, the authors recommend judicious use of existing methods for sensitivity analyses with careful assumptions; systematic assessments of whether and how known confounders have been handled, along with consideration of their prevalence and magnitude; thorough discussion of the potential for unknown confounders considering the study design and field of application; and explicit caution in making causal claims from observational studies.

Mesh:

Year:  2019        PMID: 30597486     DOI: 10.7326/M18-2159

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  19 in total

1.  Hospital Readmission Rates in Medicare Advantage and Traditional Medicare: A Retrospective Population-Based Analysis.

Authors:  Orestis A Panagiotou; Amit Kumar; Roee Gutman; Laura M Keohane; Maricruz Rivera-Hernandez; Momotazur Rahman; Pedro L Gozalo; Vincent Mor; Amal N Trivedi
Journal:  Ann Intern Med       Date:  2019-06-25       Impact factor: 25.391

2.  Are Adverse Reproductive Outcomes Associated With the Illness or Its Treatment (or Both)?

Authors:  Katherine L Wisner; Kimberly A Yonkers
Journal:  JAMA Psychiatry       Date:  2019-12-01       Impact factor: 21.596

3.  Bias Analysis Gone Bad.

Authors:  Timothy L Lash; Thomas P Ahern; Lindsay J Collin; Matthew P Fox; Richard F MacLehose
Journal:  Am J Epidemiol       Date:  2021-08-01       Impact factor: 4.897

4.  The association between silica exposure, silicosis and tuberculosis: a systematic review and meta-analysis.

Authors:  Rodney Ehrlich; Paula Akugizibwe; Nandi Siegfried; David Rees
Journal:  BMC Public Health       Date:  2021-05-20       Impact factor: 3.295

5.  Recommendations for the use of propensity score methods in multiple sclerosis research.

Authors:  Gabrielle Simoneau; Fabio Pellegrini; Thomas Pa Debray; Julie Rouette; Johanna Muñoz; Robert W Platt; John Petkau; Justin Bohn; Changyu Shen; Carl de Moor; Mohammad Ehsanul Karim
Journal:  Mult Scler       Date:  2022-04-06       Impact factor: 5.855

6.  Are E-values too optimistic or too pessimistic? Both and neither!

Authors:  Arvid Sjölander; Sander Greenland
Journal:  Int J Epidemiol       Date:  2022-05-09       Impact factor: 9.685

7.  Commentary: Continuing the E-value's post-publication peer review.

Authors:  Charles Poole
Journal:  Int J Epidemiol       Date:  2020-10-01       Impact factor: 9.685

8.  Methods for the Selection of Covariates in Nutritional Epidemiology Studies: A Meta-Epidemiological Review.

Authors:  Dena Zeraatkar; Kevin Cheung; Kirolos Milio; Max Zworth; Arnav Gupta; Arrti Bhasin; Jessica J Bartoszko; Michel Kiflen; Rita E Morassut; Salmi T Noor; Daeria O Lawson; Bradley C Johnston; Shrikant I Bangdiwala; Russell J de Souza
Journal:  Curr Dev Nutr       Date:  2019-09-17

9.  Association between gifts from pharmaceutical companies to French general practitioners and their drug prescribing patterns in 2016: retrospective study using the French Transparency in Healthcare and National Health Data System databases.

Authors:  Bruno Goupil; Frédéric Balusson; Florian Naudet; Maxime Esvan; Benjamin Bastian; Anthony Chapron; Pierre Frouard
Journal:  BMJ       Date:  2019-11-05

10.  Robustness of the Comparative Observational Evidence Supporting Class I and II Cardiac Surgery Procedures.

Authors:  Mario Gaudino; Irbaz Hameed; N Bryce Robinson; Ajita Naik; Viola Weidenmann; Yongle Ruan; Derrick Tam; Leonard N Girardi; Stephen Fremes
Journal:  J Am Heart Assoc       Date:  2020-08-20       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.